Wockhardt Ltd
Prasad Joshi has extensive experience in strategic alliance management and corporate affairs, currently serving as Assistant General Manager at Wockhardt Ltd. since May 2018, focusing on strategic outsourcing, global project management, supplier relationship management, and business development. Prior roles at Wockhardt include Senior Manager and a strong background in managing new product sourcing for various global markets, contract negotiations, and project management of outsourcing projects. Prasad's tenure at Plethico Pharmaceuticals included oversight of corporate governance, product development, and new business development in diverse international markets. Additional experience includes a managerial position at Natrol, Inc. post-acquisition, and early career experience as a medical representative at Lupin Limited. Educational qualifications include a Postgraduate Certificate in International Business from the Indian Institute of Foreign Trade and a Bachelor of Pharmacy from BVP's Poona College of Pharmacy.
This person is not in any teams
This person is not in any offices
Wockhardt Ltd
1 followers
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.